<DOC>
	<DOCNO>NCT02516111</DOCNO>
	<brief_summary>The present study design single-centre , randomize , control clinical trial evaluate compare clinical efficacy autologous PRF , 1 % alendronate ( ALN ) 1.2 % atorvastatin ( ATV ) gel placement open flap debriedement treatment intrabony defect patient chronic periodontitis .</brief_summary>
	<brief_title>Comparison Autologous PRF , 1 % Alendronate 1.2 % Atorvastatin Gel Chronic Periodontitis Treatment</brief_title>
	<detailed_description>Background : Platelet-rich fibrin ( PRF ) second-generation platelet concentrate release various growth factor promote tissue regeneration . Alendronate Atorvastatin know inhibit osteoclastic bone resorption propose osteostimulative property cause osteoblast differentiation vivo vitro show increase matrix formation . The aim present study evaluate compare efficacy autologous PRF , 1 % alendronate 1.2 % atorvastatin gel placement open flap debriedement treatment intrabony defect patient chronic periodontitis . Methods : 120 CP subject IBD ≥3 mm deep probe depth ( PD ) ≥5 mm , follow scale root planing ( SRP ) , categorize four treatment group : 1 ) OFD 2 ) OFD PRF 3 ) OFD 1 % ALN gel 4 ) OFD 1.2 % ATV gel . Clinical parameter include site specific plaque index ( PI ) , modify sulcus bleed index ( mSBI ) , probe depth ( PD ) relative attachment level ( RAL ) well percentage radiographic intrabony defect depth reduction ( DDR ) record baseline surgery 9 month post-operatively .</detailed_description>
	<mesh_term>Periodontitis</mesh_term>
	<mesh_term>Chronic Periodontitis</mesh_term>
	<mesh_term>Atorvastatin Calcium</mesh_term>
	<mesh_term>Alendronate</mesh_term>
	<criteria>Systemically healthy patient PDs ≥5mm CALs ≥4 6mm vertical bone loss ≥3 mm intraoral periapical radiograph history periodontal therapy use antibiotic precede 6 month include Patients know systemic disease Known suspect allergy ALN/ bisphosphonates ATV/statin group On systemic ALN/ bisphosphonates ATV/statin group With aggressive periodontitis Who use tobacco form Alcoholics Immunocompromised patient And pregnant lactating female exclude study</criteria>
	<gender>Female</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>August 2015</verification_date>
</DOC>